Sprung Structures Expands Presence in the Japanese Market
TOKYO, June 10, 2025 /PRNewswire/ -- Sprung Structures, a global leader in innovative building solutions, is proud to announce the expansion of its operations in Japan through a strategic alliance with WAM Co., Ltd., a multidisciplinary firm based...
Cognex Introduces OneVision: A Breakthrough Cloud Platform for AI-Powered Machine Vision
New Training Environment Delivers Scalable Automation and Solves Key Barriers to Industrial AI Adoption NATICK, Mass., June 10, 2025 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX), the global technology leader in industrial machine vision, today...
Malaysia to host first Global Skills Forum outside Geneva, under ASEAN Year of Skills
GENEVA, June 10, 2025 /PRNewswire/ -- Malaysia has been honoured with the international recognition of hosting the Global Skills Forum (GSF) 2025, marking the first time the prestigious event will be held outside of Geneva. Geneva Marks Malaysia’s...
The Hashemite Kingdom of Jordan Announces New Ocean Innovation Hub in Partnership with Innovative Blue Technology Company Voyacy Regen
Located in the Gulf of Aqaba, in the Hashemite Kingdom of Jordan, the Aqaba Marine Park will focus on building climate-resilient coastal marine infrastructure at an unprecedented scale NICE, France, June 10, 2025 /PRNewswire/ -- Today, His Majesty...
NETMARBLE UNVEILS THE SEVEN DEADLY SINS: ORIGIN OPEN-WORLD RPG FOR PLAYSTATION 5, PC AND MOBILE PLATFORMS
Pre-register Today and Secure Exclusive In-Game Reward by Visiting the Newly Launched Brand Site: https://7origin.netmarble.com/ New Trailers Debut at Summer Game Fest and Future Games Show: Summer Showcase 2025 SEOUL, South Korea, June 10, 2025...
APME Maintains Stable Hiring Outlook Amid Global Uncertainty in Q3 2025
The Net Employment Outlook for Q3 2025 in Asia Pacific and the Middle East (APME) is +28%, remaining the same as Q2 2025 and up 7 points from Q3 2024. Employers in U.A.E. (+48%), India (+42%), and China (+28%) report the strongest Outlooks in the...
VivaVision Announces Positive Comments from FDA for the Type C Meeting Regarding VVN461LD for Post-operative Infalmmation - Agreeing the Phase 2 Trial to Be Served as One of the Two Pivotal Studies.
HONG KONG and WENZHOU, China, June 10, 2025 /PRNewswire/ -- VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced today that it received written...
Eluminex Biosciences Announces Phase 1b Single Ascending Dose Study Results of a Novel Pentavalent Trispecific Fusion Antibody (EB-105) in Patients with Diabetic Macular Edema (DME)
EB-105 Targets VEGF-A, -B, PlGF, Ang-2, and IL-6R Improvements in Visual Acuity and Retinal Edema Observed at All Dose Levels No Safety Issues Observed Following a Single Intravitreal (IVT) Injection Multiple Ascending Dose Study Planned for Q3 2025...